| [1] | LAFARO KJ, DEMIRJIAN AN, PAWLIK TM. Epidemiology of hepatocellular carcinoma[J]. Surg Oncol Clin N Am,2015,24(1):1. |
| [2] | JEMAL A,BRAY F,CENTER MM,et al. Global cancer statistics[J]. CA Cancer J Clin,2011,61(2):69. |
| [3] | CHEN W,ZHENG R,ZENG H,et al. Annual report on status of cancer in China,2011[J]. Chin J Cancer Res,2015,27(1):2. |
| [4] | KAN X, JING Y, WAN QY, et al. Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma[J]. Eur Rev Med Pharmacol Sci, 2015,19(2):247. |
| [5] | GAFTON B,PORUMB V,UNGURIANU S,et al. Hepatocellular carcinoma:insights in the biological treatment beyond sorafenib[J]. J BUON,2014,19(4):858. |
| [6] | LIU WJ,REN JG,LI T,et al. 5-Aza-2< -deoxycytidine induces hepatoma cell apoptosis via enhancing methionine adenosyltransferase 1A expression and inducing S-adenosy-lmethionine production[J]. Asian Pac J Cancer Prev,2013,14(11):6433. |
| [7] | HUANG WC, HSIEH YL, HUNG CM, et al. BCRP/ABCG2 inhibition sensitizes hepatocellular carcinoma cells to sorafenib[J]. PLoS One,2013,8(12):e83627. |
| [8] | RAJENDRAN G,SHANMUGANANDAM K,BENDRE A,et al. Epigenetic regulation of DNA methyltransferases:DNMT1 and DNMT3B in gliomas[J]. J Neurooncol,2011,104(2):483. |
| [9] | HERCEG Z,PALIWAL A. Epigenetic mechanisms in hepatocellular carcinoma:how environmental factors influence the epigenome[J]. Mutat Res,2011,727(3):55. |
| [10] | FAN H,CHEN L,ZHANG F,et al. MTSS1,a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in Hepatocellular carcinoma[J]. Oncogene,2012,31(18):2298. |
| [11] | MEI C, SUN L, LIU Y, et al. Transcriptional and post-ranscriptional control of DNA methyltransferase 3B is regulated by phosphatidylinositol 3 kinase/Akt pathway in human hepatocellular carcinoma cell lines[J]. J Cell Biochem,2010, 111(1):158. |
| [12] | 陈逢生,崔彦芝,罗荣城,等. 索拉非尼联合顺铂抑制肝癌HepG2细胞生长的体外研究[J]. 解放军医学杂志,2008,33(4):397. |